文献速递肿瘤 PET/CT放射性药物与辐射防护

COVID-19疫苗接种后18F-FDG PET/CT的系统性免疫反应特征

Features of Systemic Immune Response From COVID-19 Vaccination on 18F-FDG PET/CT.
PubMed 文献 · Clin Nucl Med · 2022-01-01

一例46岁女性3A期乳腺癌随访患者,左三角肌接种COVID-19疫苗1周后行18F-FDG PET/CT,显示左腋窝淋巴结高摄取、脾脏弥漫性浓聚及骨髓中度弥漫性摄取。患者因发热住院24小时,支持治疗后症状缓解,1个月后状况良好,摄取部位被认为与系统性免疫反应相关。

要点

  • COVID-19疫苗接种后可出现腋窝淋巴结反应性增生及脾脏、骨髓弥漫性FDG摄取。
  • 上述摄取模式需与肿瘤转移或淋巴瘤浸润鉴别,结合接种史和部位判断。
  • 患者发热等症状经支持治疗缓解,短期随访状况良好。

核心结论

  • COVID-19疫苗接种后18F-FDG PET/CT可显示左腋窝淋巴结、脾脏弥漫性及骨髓中度弥漫性摄取,被认为与系统性免疫反应相关。

研究设计与样本

  • 单例病例报告:46岁女性,既往3A期乳腺癌病史,随访行18F-FDG PET/CT。

主要发现

  • PET/CT显示左腋窝淋巴结高摄取、脾脏弥漫性浓聚及骨髓中度弥漫性摄取。
  • 患者在左三角肌接种COVID-19疫苗1周后扫描,因发热住院24小时,支持治疗后症状缓解。
  • 扫描后1个月患者状况良好。

临床怎么用

  • 核医学科医生判读18F-FDG PET/CT时,应结合近期COVID-19疫苗接种史(部位、时间)解释腋窝淋巴结、脾脏和骨髓摄取。

局限性

  • 单例病例报告,无法确定因果关系或发生率;未提供定量摄取参数或病理验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The rapid rollout of COVID-19 vaccination is accompanied by incidental findings on 18F-FDG PET/CT. Most cases describe reactive axillary lymphadenopathy. A 46-year-old woman with previous history of stage 3A breast cancer underwent follow-up 18F-FDG PET/CT, which demonstrated avid left axillary nodes and intense diffuse splenic uptake and moderate diffuse bone marrow uptake. She had been administered COVID-19 vaccination in the left deltoid 1 week earlier and required hospitalization for 24 hours due to fever. Symptoms settled with supportive treatment. One month after the PET/CT scan, she remained well. Sites of uptake were taken to relate to a systemic immune response.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Nawwar AA, Searle J, Lyburn ID, et al. Features of Systemic Immune Response From COVID-19 Vaccination on 18F-FDG PET/CT. Clin Nucl Med. 2022. PMID: 34269722. doi:10.1097/RLU.0000000000003859

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。